Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the full record of transactions filed by Li Dean Y, Executive VP & President, MRL. Officer active across 2 companies, notably Merck & Co., Inc.. In total, 43 filings have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €1.8m. Activity tracked since 1 May 2021. The latest transaction was disclosed on 29 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Li Dean Y
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1062 títulos@ 115,47 US$1.5% de su flujoCommon StockSEC:0001127602-23-014248:0
25 de 43 declaraciones
About Li Dean Y
Li Dean Y is Executive VP & President, MRL. This person is also a director of Recursion Pharmaceuticals, INC. and has 43 filings in total. Among the sampled recent filings, which run from 2021-05-04 to 2026-05-01, sales total EUR 1828920 and the most frequent transaction nature is Attribution.
